EyePoint Pharmaceuticals Inc.

11.09-0.0100-0.09%Vol 116.88K1Y Perf 9.58%
Aug 11th, 2022 16:00 DELAYED
BID10.72 ASK11.74
Open10.99 Previous Close11.10
Pre-Market- After-Market11.09
 - -  - -%
Target Price
27.75 
Analyst Rating
Strong Buy 1.00
Potential %
150.23 
Finscreener Ranking
★★★★★     59.99
Insiders Trans % 3/6/12 mo.
-/100/- 
Value Ranking
★★★     52.12
Insiders Value % 3/6/12 mo.
-/100/-89 
Growth Ranking
★★★★     59.70
Insiders Shares Cnt. % 3/6/12 mo.
-/100/-82 
Income Ranking
 —    -
Price Range Ratio 52W %
28.23 
Earnings Rating
Sell
Market Cap377.85M 
Earnings Date
3rd Aug 2022
Alpha0.00 Standard Deviation0.25
Beta1.22 

Today's Price Range

10.7211.36

52W Range

7.0021.50

5 Year PE Ratio Range

-1.80-2.00

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
5.32%
1 Month
39.15%
3 Months
18.48%
6 Months
10.90%
1 Year
9.58%
3 Years
-14.69%
5 Years
-0.09%
10 Years
-38.39%

TickerPriceChg.Chg.%
EYPT11.09-0.0100-0.09
AAPL168.49-0.7500-0.44
GOOG119.82-0.8300-0.69
MSFT287.02-2.1400-0.74
XOM93.192.62002.89
WFC45.250.92002.08
JNJ167.14-3.5300-2.07
FB196.640.99000.51
GE78.901.76002.28
JPM120.141.75001.48
 
ProfitabilityValueIndustryS&P 500US Markets
78.00
-158.70
-151.60
-
-
RevenueValueIndustryS&P 500US Markets
29.90M
0.88
66.21
58.44
Earnings HistoryEstimateReportedSurprise %
Q02 2022-0.57-0.528.77
Q01 2022-0.50-0.52-4.00
Q04 2021-0.50-0.59-18.00
Q03 2021-0.47-0.58-23.40
Q02 2021-0.45-0.3522.22
Q01 2021-0.53-0.505.66
Q04 20200.45-1.01-324.44
Q03 2020-0.10-0.30-200.00
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.57-11.76Negative
9/2022 QR-0.680.00-
12/2022 FY-2.3311.74Positive
12/2023 FY-2.4417.29Positive
Next Report Date-
Estimated EPS Next Report-0.57
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume116.88K
Shares Outstanding34.07K
Shares Float21.68M
Trades Count1.82K
Dollar Volume1.30M
Avg. Volume170.10K
Avg. Weekly Volume135.12K
Avg. Monthly Volume219.17K
Avg. Quarterly Volume156.01K

EyePoint Pharmaceuticals Inc. (NASDAQ: EYPT) stock closed at 11.09 per share at the end of the most recent trading day (a -0.09% change compared to the prior day closing price) with a volume of 116.88K shares and market capitalization of 377.85M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 84 people. EyePoint Pharmaceuticals Inc. CEO is Nancy Lurker.

The one-year performance of EyePoint Pharmaceuticals Inc. stock is 9.58%, while year-to-date (YTD) performance is -9.4%. EYPT stock has a five-year performance of -0.09%. Its 52-week range is between 6.995 and 21.5, which gives EYPT stock a 52-week price range ratio of 28.23%

EyePoint Pharmaceuticals Inc. currently has a PE ratio of -4.70, a price-to-book (PB) ratio of 2.02, a price-to-sale (PS) ratio of 11.15, a price to cashflow ratio of 10.50, a PEG ratio of 2.32, a ROA of -31.86%, a ROC of -33.17% and a ROE of -48.62%. The company’s profit margin is -%, its EBITDA margin is -151.60%, and its revenue ttm is $29.90 Million , which makes it $0.88 revenue per share.

Of the last four earnings reports from EyePoint Pharmaceuticals Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.57 for the next earnings report. EyePoint Pharmaceuticals Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for EyePoint Pharmaceuticals Inc. is Strong Buy (1), with a target price of $27.75, which is +150.23% compared to the current price. The earnings rating for EyePoint Pharmaceuticals Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

EyePoint Pharmaceuticals Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

EyePoint Pharmaceuticals Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 23.87, ATR14 : 0.75, CCI20 : 113.89, Chaikin Money Flow : 0.13, MACD : 0.50, Money Flow Index : 42.99, ROC : 7.88, RSI : 63.70, STOCH (14,3) : 89.40, STOCH RSI : 0.98, UO : 58.06, Williams %R : -10.60), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of EyePoint Pharmaceuticals Inc. in the last 12-months were: Dario A. Paggiarino (Option Excercise at a value of $0), David R. Guyer (Option Excercise at a value of $0), David Scott Jones (Option Excercise at a value of $0), George O. Elston (Option Excercise at a value of $0), Goran A. Ando (Option Excercise at a value of $0), John B. Landis (Option Excercise at a value of $0), Michael C. Pine (Buy at a value of $12 210), Nancy S. Lurker (Option Excercise at a value of $0), Nancy S. Lurker (Sold 10 000 shares of value $201 480 ), Wendy F. DiCicco (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed 5 FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert and Verisome Technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases.

CEO: Nancy Lurker

Telephone: +1 617 926-5000

Address: 480 Pleasant Street, Watertown 02472, MA, US

Number of employees: 84

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

53%47%

Bearish Bullish

63%37%

TipRanks News for EYPT

Mon, 14 Feb 2022 11:18 GMT EyePoint Pharmaceuticals (EYPT) Gets a Buy Rating from H.C. Wainwright

- TipRanks. All rights reserved.

News

Stocktwits